Pfizer Ventures
Venture capital firm · Founded 2004 · New York, NY, United States · New York ↗
Pfizer Ventures is the corporate venture capital arm of Pfizer, investing in companies developing innovative therapeutics and platform technologies in areas including oncology, inflammation and immunology, cardiovascular and metabolic diseases and vaccines, from seed through IPO with an emphasis on early-stage opportunities.
Tier reflects published scale and track-record signals. It is not a rating of the firm as a partner.
This profile is unclaimed. Built from public sources. If you're a partner or employee at Pfizer Ventures, you can claim it.
Claim this profileHow claiming worksKey numbers
Assets under management
$1.3B
Latest fund
LAST CHECKED NOV 2026
Funds
LAST CHECKED NOV 2026
Check size
$5M–$20M
Stages
SeedSeries ASeries B
Sectors
OncologyInflammation & ImmunologyCardiovascularMetabolic/ObesityVaccines
FIGURES ARE AS PUBLISHED IN THE CATALOG RECORD 1 · PER-FIGURE AS-OF DATES ARE NOT YET IN THE CATALOG
Track record
Hits
- Morphic Therapeutics
Acquired by Eli Lilly ($3.2B, 2024) — BioSpace's profile of Pfizer Ventures notes portfolio company Morphic Therapeutics was acquired by Eli Lilly for $3.2 billion in 2024.
Source: biospace.com
Misses
- Ribon TherapeuticsShut down (2024)
BioSpace's profile of Pfizer Ventures notes portfolio company Ribon Therapeutics closed down in 2024.
Source: biospace.com
- MetabomedShut down (2024)
BioSpace's profile of Pfizer Ventures notes portfolio company Metabomed closed down in 2024.
Source: biospace.com
Partners 4
- Barbara Dalton
Senior Managing Partner
Board seats
No public record - Denis Patrick
Managing Partner
Board seats
No public record - Michael Baran
Partner
Board seats
No public record - Rana Al-Hallaq
Principal
Board seats
No public record
Reputation 3
No reputation score — basis not established for this firm.
- Global Venturing: standout women in CVC (Pfizer Ventures profile)
globalventuring.com
- PrivateEquityList investor profile
privateequitylist.com
Contact
Published sources only
Published contact
No contact details published by this firm.
GlassVC lists only contact information the firm or its sources have published. We do not list personal emails, direct lines, or private addresses.
Suggest a sourceWhat founders say
Founder-submitted · Verified identity and relationship
No founder reviews yet
Be the first founder to share your experience with Pfizer Ventures. Reviews come from founders whose identity and relationship have been verified.
Write the first reviewMethodology
Tier basis — Grouped by disclosed AUM of $1.3B (AUM-band grouping — full tier basis pending in the catalog). Tier reflects published scale and track-record signals. It is not a rating of the firm as a partner.
Figures are shown as published; conflicting figures are never averaged. Review dimension scores appear only once three founders have reviewed this firm; profiles below that threshold do not appear in rated lists.
The catalog does not yet carry per-figure citations or as-of dates: every figure on this page traces to the catalog record listed below, and that limit is stated rather than papered over. Corrections with a source: Suggest a correction.
Source record 1
- [1]
DATABASE · GlassVC catalog — Catalog record for Pfizer Ventures — provenance: GlassVC catalog census, November 2026
↩ cites: AUM · Check size · Founded · HQ · Stages · Sectors · Track record · Reputation
PROFILE BUILT FROM PUBLIC SOURCES · 1 CATALOG SOURCE · LAST CHECKED NOV 2026
